Men with cystic fibrosis (CF) commonly have low testosterone levels, though this is likely underrecognized due to a lack…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The lungs of people with cystic fibrosis (CF) harbor stem cells with a distinctive proinflammatory genetic signature, a new…
ReCode Therapeutics has raised $50 million in extended series B financing, which the company plans to use to help…
A type of bacteria called Achromobacter, which can cause problematic lung infections in people with cystic fibrosis (CF), uses…
CFTR — the protein whose defect or absence causes cystic fibrosis (CF) — helps cells called ionocytes remove liquid…
SPL84, an experimental treatment being developed for people with cystic fibrosis (CF) that’s caused by a specific mutation, showed a…
As more adults with cystic fibrosis (CF) choose to become parents, they face unique challenges in balancing the responsibilities…
A three-dimensional MRI scan of the lungs can be used to monitor responses by cystic fibrosis (CF) patients to the approved…
Gene therapy to deliver a modified and better working version of the CFTR protein may be more effective in treating…
Porosome Therapeutics is seeking a U.S. patent that would cover its “radically new and distinctive” technology platform for the…